Navigation Links
Boehringer Ingelheim's investigational volasertib receives FDA Breakthrough Therapy designation
Date:9/17/2013

RIDGEFIELD, Conn., Sept. 17, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib*, an investigational inhibitor of polo-like kinase (Plk), being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia (AML), ineligible for intensive remission induction therapy.

"This FDA Breakthrough Therapy designation provides Boehringer Ingelheim the opportunity to engage in an ongoing dialogue with the FDA  to help expedite the development of volasertib as a potential treatment option for these patients with AML," said Sabine Luik, M.D., senior vice president, Medicine & Regulatory Affairs, U.S. Regional Medical Director, Boehringer Ingelheim Pharmaceuticals, Inc. "Volasertib is one of many investigational compounds in Boehringer Ingelheim's growing oncology pipeline and is an example of our commitment to exploring treatment approaches with the goal of improving patient outcomes."

The Breakthrough Therapy designation process was established by the FDA in July 2012 and is intended to facilitate and expedite the development and review of drugs for serious or life-threatening conditions if  preliminary clinical evidence indicates that the therapy may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints.

AML is an aggressive cancer of the bone marrow and blood.2 It accounts for 25 percent of all adult leukemias in the Western world3 and has one of the lowest survival rates of all leukemias.3 In 2013, it is estimated there will be 14,590 new cases of AML diagnosed in the U.S. and 10,370 deaths from the disease.4

AML is primarily a disease of later adulthood; the average age of an AML patient is 65 years.5 A common treatment approach for AML
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
2. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
4. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
6. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
7. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
8. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
9. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
10. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
11. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015  Sage Analytics ( ... portable laboratory-quality cannabis potency measurement systems, announced its sponsorship ... Area Cruise Fundraiser. A limited number of tickets are ... and help a great cause while enjoying an open ... cruise around the San Francisco Bay at sunset. ...
(Date:8/3/2015)...  Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" or ... HZNP ) ("Horizon") announcement that it intends to ... a record date to determine the shareholders eligible to ... Board will review the request when it is received. ... the information required under Depomed,s bylaws, the Depomed Board ...
(Date:8/3/2015)... 3, 2015 According to ... Research "Global Market Study on Physiotherapy Equipment - ... Growth by 2022", the global physiotherapy equipment market is estimated ... of 2015 and is expected to grow at ... to account for US$23.7 Bn by 2022. ...
Breaking Medicine Technology:Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4
... Dec. 9, 2011 /PRNewswire-iReach/ -- Novel Health ... the publication of  2010-2011 market trends study called ,What,s ... The published article is an analysis of sales, pricing, ... specialty biologic products. This study highlights several emerging trends ...
... FRAMINGHAM, Mass. and SYDNEY, Dec. 9, 2011 HeartWare ... HIN), a leading innovator of less invasive, miniaturized circulatory ... heart failure, today announced that CEO Doug Godshall is ... Conference at 10:50 a.m. EST on Wednesday, December 14, ...
Cached Medicine Technology:Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 2Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 3Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 4HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference 2
(Date:8/3/2015)... Raleigh, NC (PRWEB) , ... August 03, 2015 , ... ... master by experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki ... kitchen, Zereshki has decided to share her cookbook Recipes from My Persian Kitchen with ...
(Date:8/3/2015)... Grants Pass, OR (PRWEB) , ... August 03, ... ... in Northeast California’s Modoc National Forest, to Ahjumawi Lava Springs, California’s northernmost and ... one of California’s largest untapped ground water aquifers, whose main outflow is at ...
(Date:8/3/2015)... ... 03, 2015 , ... From 2006-2017 the number of dental ... market research compiled for the National Association of Dental Laboratories ( NADL ) ... of Labor Statistics. As the number of dental laboratories decreases, dentists will have ...
(Date:8/3/2015)... Florida (PRWEB) , ... August 03, 2015 , ... Constantin ... pain accompanied by tissue injury caused by diabetes after many years of suffering and ... many times, and he didn’t want to ask for extra time off or wait ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... International Code Council (ICC) announce an agreement to collaborate across a wide ... conservation to increasing building code knowledge among architects. , “Our combined membership, consisting ...
Breaking Medicine News(10 mins):Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3
... , WEDNESDAY, Dec. 8 (HealthDay News) -- A new ... blood to scan the genome of a fetus may offer ... genetic diseases, a new study suggests. Currently, a sample ... amniocentesis or chorionic villus sampling, both of which pose a ...
... HealthDay Reporter , WEDNESDAY, Dec. 8 (HealthDay News) -- Allison Glover ... little more than two months after she gave birth to him ... seven weeks early, on Feb. 23, 2000, but both had relatively ... and living in Stone Mountain, Ga. Garrett seemed the ...
... Patients who have complications after colorectal cancer surgery ... is clearly recommended for their diagnosis, a new study ... In addition, patients with complications were more than ... more than 120 days after diagnosis or two months ...
... Learning to read and write are complex processes, which ... known as dyslexia and dysgraphia. Two new studies, published ... ( http://www.sciencedirect.com/science/journal/00109452 ) provide evidence of this variety, ... account. A group of researchers from the Universities ...
... becoming tastier and more appealing to consumers thanks to new ... forms of fiber, which could be a boon to health, ... of Chemical & Engineering News (C&EN), ACS, weekly newsmagazine. ... plays key roles in human health. Fiber creates a feeling ...
... -- Kidney failure patients who are married are more likely ... or widowers or have never married, finds a new study. ... with end-stage kidney failure. Previous research has shown that males, ... more likely than others to receive kidney transplants in the ...
Cached Medicine News:Health News:Mother Talks of the Anger, Confusion and Grief of a SIDS Death 2Health News:Mother Talks of the Anger, Confusion and Grief of a SIDS Death 3Health News:Surgery complications linked to chemotherapy delay, U-M study finds 2Health News:Widening our perceptions of reading and writing difficulties 2Health News:Marital Status May Affect Kidney Transplant Decision 2
Rad-5v signal extraction pulse oximeter™...
... The WristOx® 3100 is a ... to be worn comfortably on ... monitoring daily activities and for ... of the WristOx is intended ...
... The PulseOx 5500TM is the ... blood oxygen saturation and heart rate ... The PulseOx 5500TM uses SPO Medicals ... device which is more usable for ...
All-in-One Fingertip Oximeter...
Medicine Products: